tiprankstipranks
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market

Puma Biotechnology (PBYI) Income Statement

Compare
633 Followers

Puma Biotechnology Income Statement

Last quarter (Q3 2024), Puma Biotechnology's total revenue was $80.54M, an increase of 43.53% from the same quarter last year. In Q3, Puma Biotechnology's net income was $20.32M. See Puma Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 235.64M$ 228.00M$ 253.20M$ 225.10M$ 272.30M
Gross Profit
$ 172.96M$ 172.90M$ 189.50M$ 185.70M$ 235.50M
Operating Expenses
$ 140.31M$ 142.20M$ 188.20M$ 216.10M$ 274.60M
Depreciation and Amortization
$ 11.52M$ 8.92M$ 10.60M$ 7.20M$ 4.80M
EBITDA
$ 47.52M$ 20.97M$ -5.40M$ -38.54M$ -55.72M
Operating Income
$ 32.64M$ 23.70M$ -8.90M$ -30.40M$ -39.10M
Other Income/Expenses
$ -9.97M$ -23.26M$ -30.09M$ -29.39M$ 53.00K
Pretax Income
$ 22.67M$ 500.00K$ -28.80M$ -59.80M$ -75.60M
Net Income
$ 21.59M$ 912.00K$ -29.10M$ -60.00M$ -82.72M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.46$ 0.02$ -0.72$ -1.52$ -2.13
Diluted EPS
$ 0.45$ 0.02$ -0.72$ -1.52$ -2.13
Weighted Average Shares Outstanding
47.13M 44.67M 40.64M 39.58M 38.77M
Weighted Average Shares Outstanding (Diluted)
47.55M 44.93M 40.64M 39.58M 38.77M
Currency in USD

Puma Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis